L.E.K. · consulting-deck
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report
58 pages · 3 arc beats · 1 loops
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report
L.E.K. arc beats above · slides in the middle · loops below · scroll → 1 LOOPS
1246810121416182022242628303234363840424446485052545658
Deck intelligence map
3 coverage by narrative range · generated from this deck JSON
Narrative range 20 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Situation & Context 5 slides 100% 5/5 slides 100% 5/5 slides · 22 hits 20% 1/5 slides 80% 4/5 slides — 0/5 slides
100% 5/5 slides — 0/5 slides
Problem & Complication 6 slides 100% 6/6 slides 100% 6/6 slides · 42 hits 50% 3/6 slides 66.7% 4/6 slides · 6 hits 16.7% 1/6 slides 100% 6/6 slides 16.7% 1/6 slides Solution & Approach 9 slides 100% 9/9 slides 100% 9/9 slides · 56 hits 55.6% 5/9 slides 11.1% 1/9 slides 11.1% 1/9 slides 100% 9/9 slides 100% 9/9 slides Slide inventory
58 every slide · same image gating as the playbook
05
The table is segmented into three thematic blocks: demographics, economic indicators, and healthcare market metrics.compare_peers
Open slide detailBeat · Situation & Context
06
Uses a PEST framework (Policy, Economy, Society, Technology) to structure the market analysis.diagnose
Open slide detailBeat · Problem & Complication
07
The slide uses a comparative bar chart structure to contrast high growth in China (29% CAGR) against stable growth in the U.S. (3% CAGR).summarize
Open slide detailBeat · Problem & Complication
08
The slide uses a honeycomb layout to group regulatory initiatives. Color coding indicates the nature of the policy (R&D, Registration, Pricing/Market Access, Cosummarize
Open slide detailBeat · Problem & Complication
09
The slide uses stacked bar charts to show the composition of clinical trials by phase (I, II, III) for China and the US.analyze_data
Open slide detailBeat · Problem & Complication
10
Data refers to enterprises above designated annual revenue size (>20M RMB). Exchange rate 6.25 used.analyze_data
Open slide detailBeat · Problem & Complication
12
The slide combines quantitative survey data (N=101) with qualitative expert quotes to contextualize the market sentiment.summarize
16
The chart uses a broken y-axis to accommodate the large number of companies in the 1-5 project range.analyze_data
17
The chart displays 4 categories of FDA designations with stacked segments representing product types.analyze_data
18
The slide highlights the 'me-too' drug development problem in China.frame_problem
19
The slide uses a dual-column layout to contrast market drivers (left) with specific regulatory examples (right).establish_context
20
The slide uses a stacked bar chart to show survey responses and a callout box for qualitative expert feedback.summarize
21
The slide uses stacked bar charts to show clinical trial phases over time, with CAGR annotations.analyze_data
22
The slide uses a three-row structure to map strategic pillars to real-world examples and qualitative expert validation.illustrate_case
24
The chart shows a clear shift in clinical trial focus toward oncology, increasing from 30% in 2016 to 48% in 2022.analyze_data
25
Uses a 'Past vs Future' transformation framework to illustrate strategic shift.summarize
26
The chart highlights factors directly related to commercial attractiveness in green.analyze_data
27
The chart uses a 7-point Likert scale. The top 4 categories are highlighted in green.analyze_data
28
The slide uses a list format with icons to categorize qualitative feedback from interviews.summarize
30
The slide uses a structured table to map trends to operational/technical complexity and their specific implications.establish_context
31
The slide uses a chronological framework to explain the shift from paper-based to integrated digital platforms in clinical trials.establish_context
32
The chart combines a horizontal bar chart for penetration rates with a stakeholder usage matrix.analyze_data
34
The slide uses a combination of quantitative survey data and qualitative expert quotes to validate the trend towards smart clinical trial formats.summarize
35
The slide tracks the progression of Chinese regulatory guidelines (CDE) towards patient-centric and remote clinical trial methodologies.establish_context
36
The slide uses a split-layout to contrast positive drivers against negative barriers.compare_options
37
The slide uses a visual bridge to connect the 'Likely'/'Highly Likely' and 'Unlikely'/'Not Possible' segments of the survey to their respective rationales.analyze_data
39
The slide uses a circular flow diagram to represent a reciprocal relationship between two market actors.present_framework
41
The slide uses stacked bar charts to show ranking preferences (Top 1, 2, 3) for destinations and simple bar charts for decision factors.analyze_data
43
The chart displays quarterly deal numbers, showing significant volatility but a clear increase in peak deal activity post-2018.analyze_data
44
The slide highlights the trend of international pharma companies licensing innovative assets from Chinese biotech firms.illustrate_case
45
The slide highlights a strategic shift in MNC R&D presence in China, moving towards collaborative incubation models.illustrate_case
46
The slide uses a stacked bar chart to represent survey data (N=81) and includes two testimonial quotes from R&D leads.summarize
48
The slide uses a lightbulb and question mark icon to signify strategic inquiry.frame_problem
50
The slide presents qualitative interview profiles and quantitative survey respondent demographics.other